Ambrisentan in Patients With Porto-pulmonary Hypertension A Multicenter Open Label Trial (Portopulm)

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2014 by Tufts Medical Center
Sponsor:
Collaborator:
Gilead Sciences
Information provided by (Responsible Party):
Tufts Medical Center
ClinicalTrials.gov Identifier:
NCT01224210
First received: October 18, 2010
Last updated: July 22, 2014
Last verified: July 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2015
  Estimated Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)